Asunto(s)
Cámara Anterior/patología , Lesiones Oculares/complicaciones , Migración de Cuerpo Extraño/etiología , Lentes Intraoculares , Trastornos de la Pupila/etiología , Heridas no Penetrantes/complicaciones , Cámara Anterior/cirugía , Extracción de Catarata , Migración de Cuerpo Extraño/diagnóstico , Migración de Cuerpo Extraño/fisiopatología , Gonioscopía , Humanos , Implantación de Lentes Intraoculares , Masculino , Persona de Mediana Edad , Trastornos de la Pupila/diagnóstico , Trastornos de la Pupila/fisiopatología , Reoperación , Agudeza Visual/fisiologíaRESUMEN
AIM: To report the authors' experience with the use of opaque intraocular lenses (IOL) in diplopia unresponsive to traditional management strategies, and to assess patients' satisfaction and the visual function of patients following insertion of opaque IOL using the Visual Function Index (VF-14). SETTINGS: Royal Victoria Infirmary, Newcastle upon Tyne, UK. METHOD: Data were obtained on all patients who underwent insertion of an opaque IOL at our institution between 2002 and 2006. Patients were interviewed by telephone. Any visual function impairment was assessed using the VF-14 questionnaire. Patients were also asked to score subjectively their overall satisfaction with the visual outcome after opaque IOL insertion. RESULTS: The authors studied 12 patients (n = 12) who had insertion of opaque IOL. All patients had constant and persistent diplopia unresponsive to other treatments acceptable to the patient. The median duration of diplopia was 5.5 years (interquartile range was 2.4-17.3 years). The postoperative VF-14 ranged from 75 to 100, and the mean VF-14 was 91 (95% CI 83-99). Three patients reported a maximum score of 100. Patient satisfaction ranged from 2 to 4, and the average was 3.4 out of 4. CONCLUSIONS: Opaque IOL insertion is a valuable option in the management of intractable diplopia. The VF-14 revealed very little or no impairment in visual function following the procedure. All patients reported improvement in their visual function and were pleased with the final outcome.
Asunto(s)
Diplopía/cirugía , Lentes Intraoculares , Actividades Cotidianas , Adulto , Anciano , Diplopía/etiología , Diplopía/fisiopatología , Femenino , Humanos , Implantación de Lentes Intraoculares/métodos , Masculino , Persona de Mediana Edad , Satisfacción del Paciente , Diseño de Prótesis , Dispersión de Radiación , Resultado del Tratamiento , Pruebas de Visión/métodos , Agudeza VisualAsunto(s)
Endoftalmitis/diagnóstico , Infecciones Bacterianas del Ojo/diagnóstico , Infecciones Fúngicas del Ojo/diagnóstico , Streptococcus anginosus/aislamiento & purificación , Diagnóstico Diferencial , Endocarditis Bacteriana/complicaciones , Endoftalmitis/etiología , Infecciones Bacterianas del Ojo/etiología , Infecciones Fúngicas del Ojo/etiología , Humanos , Masculino , Persona de Mediana EdadRESUMEN
PURPOSE: To report a case of acute retinal necrosis presenting as central retinal artery occlusion with cilioretinal sparing. METHODS: Single interventional case report. The findings of the ophthalmic examination, MRI, blood parameters, biopsy results and clinical course are reported. RESULTS: A forty two year old gentleman reporting sudden loss of sight, ophthalmic examination revealing uveitis, central retinal artery occlusion with cilioretinal sparing and peripheral necrotizing retinitis. CONCLUSIONS: Central retinal artery occlusion can be an early feature of acute retinal necrosis (ARN).
Asunto(s)
Arterias Ciliares/patología , Oclusión de la Arteria Retiniana/diagnóstico , Arteria Retiniana/patología , Síndrome de Necrosis Retiniana Aguda/diagnóstico , Adulto , Humanos , Imagen por Resonancia Magnética , MasculinoRESUMEN
PURPOSE: To report hypo-estrogenemic state in a case of recurrent vitreous hemorrhages due to primary antiphospholipid antibody syndrome. METHODS: Interventional case report. A 40-year-old woman presented with recurrent vitreous hemorrhages. Treated initially with laser photocoagulation followed by hormone replacement therapy. RESULTS: Cessation of vitreous hemorrhage since starting hormone replacement therapy (twenty months ago). CONCLUSIONS: This is the first documented case of hypo-estrogenemia in lupus anticoagulant retinopathy. The response of this condition to estrogen is worth exploring.
Asunto(s)
Síndrome Antifosfolípido/complicaciones , Estrógenos/deficiencia , Enfermedades de la Retina/etiología , Vasos Retinianos/efectos de los fármacos , Hemorragia Vítrea/etiología , Adulto , Síndrome Antifosfolípido/diagnóstico , Síndrome Antifosfolípido/terapia , Estrógenos/administración & dosificación , Femenino , Angiografía con Fluoresceína , Humanos , Fotocoagulación/métodos , Inhibidor de Coagulación del Lupus/sangre , Enfermedades de la Retina/diagnóstico , Enfermedades de la Retina/terapia , Vasos Retinianos/patología , Resultado del Tratamiento , Agudeza Visual , Hemorragia Vítrea/diagnóstico , Hemorragia Vítrea/terapiaRESUMEN
PURPOSE: To report hypo-estrogenemic state in a case of recurrent vitreous hemorrhages due to primary antiphospholipid antibody syndrome. METHODS: Interventional case report. A 40-year-old woman presented with recurrent vitreous hemorrhages. Treated initially with laser photocoagulation followed by hormone replacement therapy. RESULTS: Cessation of vitreous hemorrhage since starting hormone replacement therapy (twenty months ago). CONCLUSIONS: This is the first documented case of hypo-estrogenemia in lupus anticoagulant retinopathy. The response of this condition to estrogen is worth exploring. (Eur J Ophthalmol 2003; 13: 819-21).
